All In Biotech

Free tool

FAERS Monitor: Saphris

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022117 or its brand name (Saphris, Asenapine Maleate). Reports on generic versions are filed under their own applications.

Reports

7,825

Serious

3,466

44% of reports

Hospitalization

1,144

Death reported

279

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective806
  • sedation667
  • suicide attempt651
  • inappropriate schedule of drug administration557
  • weight increased537
  • dyskinesia520
  • dystonia496
  • blood glucose increased477
  • sexual dysfunction427
  • anosognosia423
  • blood prolactin abnormal413
  • metabolic disorder413
  • disturbance in social behaviour410
  • akathisia398
  • personality change385

Reports by year received

View as table
YearReports
200917
20101,716
20111,017
20121,003
20131,397
2014197
2015152
2016279
2017215
2018206
2019306
2020241
2021265
2022288
2023232
2024111
2025109
202674

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,334 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anosognosiaSignal4233297.72865.6624,793
blood prolactin abnormalSignal4132468.52163.9529,900
disturbance in social behaviourSignal410566.1510.1190,619
metabolic disorderSignal413205.7186.677,987
personality changeSignal385116.2105.242,046
sexual dysfunctionSignal427101.592.440,889
akathisiaSignal39880.773.230,366
dystoniaSignal49670.564.733,084
sedationSignal66770.265.244,340
dyskinesiaSignal52034.832.016,864
suicide attemptSignal65129.227.117,537
inappropriate schedule of drug administrationSignal55721.219.610,655
blood glucose increasedSignal4776.86.32,378
weight increasedSignal5376.56.02,493
drug ineffective8061.61.5216

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.